knowledge -WSS

knowledge

author：entertainment 2025-10-02 00:30:19 - browse：88128

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： See how much Covid

WSS

First transplant of an entire human eye performed

Today's health inequities arise from racist U.S. history, say experts

Ohio still needs to do more to protect the right to abortion

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

White House drug czar issues call for 'recovery

Cord blood banking comes at a high cost to babies

focus

knowledge

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

Ionis drug prevents swelling attacks due to hereditary angioedema

Novavax promises a turnaround & Lilly roils the obesity market

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Affirmative action in medical school literally saved lives

NIH documents show early flaws of $1.6 billion long Covid program

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Ultragenyx gene therapy for rare liver ailment succeeds in late

Dobbs anniversary: the lost opportunity of abortion as health care

NIH documents show early flaws of $1.6 billion long Covid program

leisure time

First transplant of an entire human eye performed

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Woman returns to dialysis after doctors remove transplanted pig kidney

At ASCO, AstraZeneca reports strong data for breast cancer drug

See how much Covid

Ventyx halts psoriasis drug development after lackluster trial results

hotspot

leisure time

knowledge

leisure time